作者：
Sahdeo,S. [1]
;
Wallace,T. [2]
;
Hirakawa,R. [3]
;
Knoflach,F. [4]
;
Bertrand,D. [5]
;
Maag,H. [6]
;
Misner,D. [7]
;
Tombaugh,G.C. [8]
;
Santarelli,L. [9]
;
Brameld,K. [10]
;
Milla,M.E. [11]
;
Button,D.C.
作者单位：
Roche Palo Alto, Palo Alto, CA, United States, Janssen Research and Development, San Diego, CA
[1]
HiQScreen Sarl, Geneva, Switzerland
[2]
Roche Palo Alto, Palo Alto, CA, United States, Chemistry and Drug Discovery Consulting LLC
[3]
Roche Palo Alto, Palo Alto, CA, United States, Acorda Therapeutics, Inc., 420 Saw Mill River Road
[4]
GRED, South San Francisco, CA, United States
[5]
Roche Palo Alto, Palo Alto, CA, United States, Gilead Sciences Inc., Palo Alto, CA, United States
[6]
Roche Palo Alto, Palo Alto, CA, United States, Principia Biopharma, South San Francisco, CA, United
[7]
Psychogenics Inc., Tarrytown, NY, United States
[8]
Roche Palo Alto, Palo Alto, CA, United States, SRI International, Menlo Park, CA, United States
[9]
Roche Palo Alto, Palo Alto, CA, United States, Molecular Biosciences, School of Veterinary Medicine
[10]
F. Hoffmann-La Roche AG, PRED, Pharma Research and Early Development, Discovery Neuroscience
[11]
发布时间
2014-12-13
换一批
